Description
(ELDISINE is registered trademarks GENUS PHARMACEUTICALS LIMITED)
Eldisine – Vindesine Sulphate 5 mg is supplied for Tenders, Emergency imports, Orphan drug, Reference listed drugs, Comparator Drug, Name patient medicine and Innovator samples etc.
What is ELDISINE:
ELDISINE is a medicine that contains the active substance Vindesine Sulphate and is available as a Vial.
In how many countries ELDISINE is approved for marketing?
ELDISINE is available/approved in USA and Europe. We can help you to access it in India.
What is ELDISINE used for?
ELDISINE is indicated for the treatment of acute lymphoblastic leukaemia of childhood resistant to other drugs;
- blastic crises of chronic myeloid leukaemia
- malignant melanoma unresponsive to other forms of therapy
- advanced carcinoma of the breast, unresponsive to appropriate endocrine surgery and/or hormonal therapy.
How can I get ELDISINE in India?
ELDISINE is a prescription only drug and is not approved for marketing in India.
The Indian Pharma (IP) is a consulting pharmaceutical company which assists Patients in accessing medicines in India. The Indian Pharma facilitates such access only against valid prescriptions in conformity with all local laws and regulations.
Patients/ Clinicians / Researchers can contact IP at +91-120-4080562 or write to at – info@theindianpharma.com
We facilitate by-
- Helping in documentation to import the medicine for personal use
- Finding Genuine and reliable source in USA, Europe and Japan
- Ensuring 100% transparency.
ELDISINE can be shipped to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India.
The Indian Pharma can facilitate the supply of ELDISINE (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement.
The Indian Pharma does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees.